APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dulaglutide Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dulaglutide Injection Market Outlook and Growth Opportunities 2026

Report ID 173986960426 December 2025194 pages

Choose your research edition.

Industry ResearchDulaglutide Injection Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Dulaglutide Injection Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Dulaglutide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dulaglutide Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dulaglutide Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dulaglutide Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dulaglutide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dulaglutide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dulaglutide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dulaglutide Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dulaglutide Injection market include Eli Lilly and Company and Boan Biotech among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dulaglutide Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dulaglutide Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dulaglutide Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dulaglutide Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Dulaglutide Injection Segment by Company

Eli Lilly and Company

Boan Biotech

Dulaglutide Injection Segment by Type

0.75 mg/0.5 mL

1.5 mg/0.5 mL

3 mg/0.5 mL

4.5 mg/0.5 mL

Dulaglutide Injection Segment by Application

Adults

Children

Dulaglutide Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dulaglutide Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dulaglutide Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dulaglutide Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Dulaglutide Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dulaglutide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dulaglutide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dulaglutide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dulaglutide Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dulaglutide Injection industry.

Chapter 3: Detailed analysis of Dulaglutide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dulaglutide Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dulaglutide Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dulaglutide Injection Industry Trends Table 2. Dulaglutide Injection Industry Drivers Table 3. Dulaglutide Injection Industry Opportunities and Challenges Table 4. Dulaglutide Injection Industry Restraints Table 5. Global Dulaglutide Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dulaglutide Injection Revenue Share by Company (2021-2026) Table 7. Global Dulaglutide Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Dulaglutide Injection Sales Volume Share by Company (2021-2026) Table 9. Global Dulaglutide Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Dulaglutide Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dulaglutide Injection Key Company Manufacturing Base & Headquarters Table 12. Global Dulaglutide Injection Company, Product Type & Application Table 13. Global Dulaglutide Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dulaglutide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.75 mg/0.5 mL Table 18. Significant Companies of 1.5 mg/0.5 mL Table 19. Significant Companies of 3 mg/0.5 mL Table 20. Significant Companies of 4.5 mg/0.5 mL Table 21. Global Dulaglutide Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Dulaglutide Injection Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Dulaglutide Injection Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Dulaglutide Injection Sales Volume Share by Type (2021-2026) Table 25. Global Dulaglutide Injection Sales Volume Share by Type (2027-2032) Table 26. Global Dulaglutide Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Dulaglutide Injection Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Dulaglutide Injection Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Dulaglutide Injection Sales Value Share by Type (2021-2026) Table 30. Global Dulaglutide Injection Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Adults Table 32. Significant Companies of Children Table 33. Global Dulaglutide Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Dulaglutide Injection Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Dulaglutide Injection Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Dulaglutide Injection Sales Volume Share by Application (2021-2026) Table 37. Global Dulaglutide Injection Sales Volume Share by Application (2027-2032) Table 38. Global Dulaglutide Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Dulaglutide Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Dulaglutide Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Dulaglutide Injection Sales Value Share by Application (2021-2026) Table 42. Global Dulaglutide Injection Sales Value Share by Application (2027-2032) Table 43. Global Dulaglutide Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Dulaglutide Injection Sales by Region (2021-2026) & (K Units) Table 45. Global Dulaglutide Injection Sales Market Share by Region (2021-2026) Table 46. Global Dulaglutide Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Dulaglutide Injection Sales Market Share by Region (2027-2032) Table 48. Global Dulaglutide Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Dulaglutide Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Dulaglutide Injection Sales Value Share by Region (2021-2026) Table 51. Global Dulaglutide Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Dulaglutide Injection Sales Value Share by Region (2027-2032) Table 53. Global Dulaglutide Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Dulaglutide Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Dulaglutide Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Dulaglutide Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Dulaglutide Injection Sales by Country (2021-2026) & (K Units) Table 58. Global Dulaglutide Injection Sales Market Share by Country (2021-2026) Table 59. Global Dulaglutide Injection Sales by Country (2027-2032) & (K Units) Table 60. Global Dulaglutide Injection Sales Market Share by Country (2027-2032) Table 61. Global Dulaglutide Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Dulaglutide Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Dulaglutide Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Dulaglutide Injection Sales Value Market Share by Country (2027-2032) Table 65. Eli Lilly and Company Company Information Table 66. Eli Lilly and Company Business Overview Table 67. Eli Lilly and Company Dulaglutide Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Eli Lilly and Company Dulaglutide Injection Product Portfolio Table 69. Eli Lilly and Company Recent Development Table 70. Boan Biotech Company Information Table 71. Boan Biotech Business Overview Table 72. Boan Biotech Dulaglutide Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Boan Biotech Dulaglutide Injection Product Portfolio Table 74. Boan Biotech Recent Development Table 75. Key Raw Materials Table 76. Raw Materials Key Suppliers Table 77. Dulaglutide Injection Distributors List Table 78. Dulaglutide Injection Customers List Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Dulaglutide Injection Product Image Figure 2. Global Dulaglutide Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dulaglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dulaglutide Injection Sales (2021-2032) & (K Units) Figure 5. Global Dulaglutide Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Dulaglutide Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.75 mg/0.5 mL Image Figure 10. 1.5 mg/0.5 mL Image Figure 11. 3 mg/0.5 mL Image Figure 12. 4.5 mg/0.5 mL Image Figure 13. Global Dulaglutide Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Dulaglutide Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Dulaglutide Injection Sales Volume Share by Type (2021-2032) Figure 16. Global Dulaglutide Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Dulaglutide Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Dulaglutide Injection Sales Value Share by Type (2021-2032) Figure 19. Adults Image Figure 20. Children Image Figure 21. Global Dulaglutide Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Dulaglutide Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Dulaglutide Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Dulaglutide Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Dulaglutide Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Dulaglutide Injection Sales Value Share by Application (2021-2032) Figure 27. Global Dulaglutide Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Dulaglutide Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Dulaglutide Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Dulaglutide Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Dulaglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Dulaglutide Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Dulaglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Dulaglutide Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Dulaglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Dulaglutide Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Dulaglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Dulaglutide Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Dulaglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Dulaglutide Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Dulaglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Dulaglutide Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Dulaglutide Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 0.75 mg/0.5 mL
  • 1.5 mg/0.5 mL
  • 3 mg/0.5 mL
  • 4.5 mg/0.5 mL
Applications
  • Adults
  • Children
Companies covered
  • Eli Lilly and Company
  • Boan Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dulaglutide Injection Sales Value (2021-2032)
  4. 1.2.2 Global Dulaglutide Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Dulaglutide Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dulaglutide Injection Market Dynamics
  1. 2.1 Dulaglutide Injection Industry Trends
  2. 2.2 Dulaglutide Injection Industry Drivers
  3. 2.3 Dulaglutide Injection Industry Opportunities and Challenges
  4. 2.4 Dulaglutide Injection Industry Restraints
3 Dulaglutide Injection Market by Company
  1. 3.1 Global Dulaglutide Injection Company Revenue Ranking in 2025
  2. 3.2 Global Dulaglutide Injection Revenue by Company (2021-2026)
  3. 3.3 Global Dulaglutide Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Dulaglutide Injection Average Price by Company (2021-2026)
  5. 3.5 Global Dulaglutide Injection Company Ranking (2024-2026)
  6. 3.6 Global Dulaglutide Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Dulaglutide Injection Company Product Type and Application
  8. 3.8 Global Dulaglutide Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dulaglutide Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dulaglutide Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dulaglutide Injection Market by Type
  1. 4.1 Dulaglutide Injection Type Introduction
  2. 4.1.1 0.75 mg/0.5 mL
  3. 4.1.2 1.5 mg/0.5 mL
  4. 4.1.3 3 mg/0.5 mL
  5. 4.1.4 4.5 mg/0.5 mL
  6. 4.2 Global Dulaglutide Injection Sales Volume by Type
  7. 4.2.1 Global Dulaglutide Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Dulaglutide Injection Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Dulaglutide Injection Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Dulaglutide Injection Sales Value by Type
  11. 4.3.1 Global Dulaglutide Injection Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Dulaglutide Injection Sales Value by Type (2021-2032)
  13. 4.3.3 Global Dulaglutide Injection Sales Value Share by Type (2021-2032)
5 Dulaglutide Injection Market by Application
  1. 5.1 Dulaglutide Injection Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Dulaglutide Injection Sales Volume by Application
  5. 5.2.1 Global Dulaglutide Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Dulaglutide Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Dulaglutide Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Dulaglutide Injection Sales Value by Application
  9. 5.3.1 Global Dulaglutide Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Dulaglutide Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Dulaglutide Injection Sales Value Share by Application (2021-2032)
6 Dulaglutide Injection Regional Sales and Value Analysis
  1. 6.1 Global Dulaglutide Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dulaglutide Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Dulaglutide Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Dulaglutide Injection Sales by Region (2027-2032)
  5. 6.3 Global Dulaglutide Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dulaglutide Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dulaglutide Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dulaglutide Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Dulaglutide Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dulaglutide Injection Sales Value (2021-2032)
  12. 6.6.2 North America Dulaglutide Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dulaglutide Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Dulaglutide Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dulaglutide Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dulaglutide Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dulaglutide Injection Sales Value (2021-2032)
  21. 6.9.2 South America Dulaglutide Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dulaglutide Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dulaglutide Injection Sales Value Share by Country, 2025 VS 2032
7 Dulaglutide Injection Country-level Sales and Value Analysis
  1. 7.1 Global Dulaglutide Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dulaglutide Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dulaglutide Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Dulaglutide Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Dulaglutide Injection Sales by Country (2027-2032)
  6. 7.4 Global Dulaglutide Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dulaglutide Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dulaglutide Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dulaglutide Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dulaglutide Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dulaglutide Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eli Lilly and Company
  2. 8.1.1 Eli Lilly and Company Company Information
  3. 8.1.2 Eli Lilly and Company Business Overview
  4. 8.1.3 Eli Lilly and Company Dulaglutide Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eli Lilly and Company Dulaglutide Injection Product Portfolio
  6. 8.1.5 Eli Lilly and Company Recent Developments
  7. 8.2 Boan Biotech
  8. 8.2.1 Boan Biotech Company Information
  9. 8.2.2 Boan Biotech Business Overview
  10. 8.2.3 Boan Biotech Dulaglutide Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boan Biotech Dulaglutide Injection Product Portfolio
  12. 8.2.5 Boan Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dulaglutide Injection Value Chain Analysis
  2. 9.1.1 Dulaglutide Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dulaglutide Injection Sales Mode & Process
  6. 9.2 Dulaglutide Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dulaglutide Injection Distributors
  9. 9.2.3 Dulaglutide Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst